Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Nora AI
  • Q&A
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

A high risk high reward Finnish AI-stock, but not for your grandmothers portfolio

By Antti LuiroHead of Nordic ER Development, Analyst
Aiforia Technologies

Aiforia is a software company at a commercially early stage whose products enable AI-based image analysis in medicine. The software's primary application is in pathology, where it helps pathologists analyze tissue samples taken from patients. Analyst Antti Luiro comments.

Read the extensive report here https://www.inderes.se/research/aiforia-promisingly-started-growth-journey-just-beginning

Follow Aiforia https://www.inderes.se/companies/Aiforia-Technologies

00:00 Intro
00:27 The big problem Aiforia tries to solve
02:45 How does Aiforia make money?
04:10 Market potential
10:50 Business stickiness
13:35 Dilution risk
16:00 Investment case

Recent videos

Truecaller, Webcast, Press Conference, 2025
2025-12-15 13:00 Truecaller
Herantis Pharma as an Investment | Life Science Night Dec 9, 2025
LIVE
2025-12-15 13:00 Herantis Pharma
Orion as an Investment | Life Science Night Dec. 9, 2025
2025-12-13 12:50 Orion
A sit-down with CEO Remco Westermann
2025-12-12 09:09 Verve Group
Aiforia as an Investment | Life Science Night Dec 9, 2025
2025-12-11 11:00 Aiforia Technologies
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.